Tristan Richards+FollowWhy Merck Walked Away From a $30B DealSo, Merck just hit pause on buying Revolution Medicines after they couldn’t agree on the price tag—think of it like haggling over a used car, but with billions at stake. If you’re following the pharma world, this means no new blockbuster cancer drug in Merck’s shopping cart (for now). But keep an eye out: Revolution could still get scooped up by someone else, and that could shake up cancer treatment options down the road. #Business #EntrepreneurshipStartup #Merck00Share